PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 37 filers reported holding PROQR THRAPEUTICS N V in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 40,000 | $335,000 | 4.05% |
| Opaleye Management Inc. | 1,424,200 | $11,921,000 | 2.23% |
| Prosight Management, LP | 282,256 | $2,362,000 | 1.30% |
| RTW INVESTMENTS, LP | 6,443,113 | $53,929,000 | 0.81% |
| DAFNA Capital Management LLC | 296,383 | $2,481,000 | 0.66% |
| Kerrisdale Advisers, LLC | 453,182 | $3,793,000 | 0.41% |
| Altium Capital Management LP | 125,000 | $1,046,000 | 0.27% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,079,668 | $17,407,000 | 0.21% |
| Alpha Paradigm Partners, LLC | 44,323 | $371,000,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 137,003 | $1,147,000 | 0.12% |